Top Markets
#1 Black Phoenix Black Phoenix +829.59%
#2 pipedog pipedog +41.28%
#3 PondCoin PondCoin +35.42%
#4 Bless Bless +35.40%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#6 SAFEcoin SAFEcoin +26.00%
#7 Beam Beam +24.62%
#8 Seeker Seeker +21.01%
#9 Magma Finance Magma Finance +20.64%
#10 YFSX YFSX +16.15%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rang in aandelen #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aandeelprijs
$64.97
Laatst gesynchroniseerd: 2024-05-20
Marktkapitalisatie
$1.97B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Categorie

Healthcare
EPS voor Alpine Immune Sciences, Inc. (ALPN)
EPS per March 2024 TTM: $-0.69
Volgens de laatste financiële rapporten en de aandelenkoers van Alpine Immune Sciences, Inc. is de huidige EPS van het bedrijf (TTM) $-0.69. Eind 2022 had het bedrijf een EPS van $-1.73, een daling ten opzichte van de EPS van 2021 die $-1.98 bedroeg.
EPS-geschiedenis van Alpine Immune Sciences, Inc. van 2012 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.69 7.81%
2023 $-0.64 -63.01%
2022 $-1.73 -12.63%
2021 $-1.98 47.76%
2020 $-1.34 -42.24%
2019 $-2.32 -11.79%
2018 $-2.63 119.17%
2017 $-1.20 -85.22%
2016 $-8.12 -16.63%
2015 $-9.74 47.80%
2014 $-6.59 -7.18%
2013 $-7.10 69.05%
2012 $-4.20 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,610.14%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -4,120.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 666.67%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 1,056.52%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH